Pharmacovigilance is an important part of healthcare regulation in India. It focuses on identifying, assessing, understanding, and preventing safety problems related to medicines and certain medical products after they are placed on the market.
The Central Drugs Standard Control Organization (CDSCO) plays an important role in regulating drugs, medical devices, and cosmetics in India. For companies operating in these sectors, regulatory compliance does not end after obtaining a licence or approval. They also need to monitor product safety and take appropriate action when safety concerns arise.
CDSCO's post-marketing drug safety framework includes monitoring adverse drug reactions, reviewing safety information, and submitting periodic safety reports where applicable. CDSCO also works with the Pharmacovigilance Programme of India (PvPI) and the Indian Pharmacopoeia Commission for drug safety monitoring.
What Is Pharmacovigilance?
Pharmacovigilance means monitoring the safety of medicines after they are approved and made available to patients.
The main purpose is to identify unexpected or previously unknown safety issues. Companies may receive safety information from doctors, patients, hospitals, distributors, clinical studies, or other sources.
Pharmacovigilance activities can include:
Collecting adverse drug reaction reports
Recording and evaluating safety information
Identifying possible safety signals
Investigating serious adverse events
Preparing safety reports
Maintaining proper safety records
Taking corrective or preventive action when required
Communicating important safety information to regulators
For applicable products, CDSCO requires Marketing Authorization Holders to maintain appropriate pharmacovigilance systems and report safety information to the relevant authorities.
Why Is Pharmacovigilance Important?
A product may go through testing before approval, but its use in the wider population can reveal additional safety information.
For example, a medicine may be used by thousands or millions of people with different ages, health conditions, medicines, and lifestyles. Some uncommon adverse reactions may therefore become visible only after wider use.
Pharmacovigilance helps companies and regulators:
Protect patients
Detect new safety concerns
Monitor known risks
Maintain a favourable benefit-risk balance
Take appropriate regulatory action
Improve product safety throughout its lifecycle
CDSCO's post-marketing safety framework includes review of Periodic Safety Update Reports (PSURs) and follow-up regulatory action where required.
Key Pharmacovigilance Requirements Under CDSCO
The exact requirements depend on the type of product, its regulatory status, and the applicable rules. However, businesses should generally focus on the following areas.
1. Establish a Pharmacovigilance System
Where required, the applicant or Marketing Authorization Holder should have a system for collecting, processing, evaluating, and forwarding adverse reaction information.
The system should clearly define who is responsible for receiving safety complaints, evaluating reports, maintaining records, and communicating with the regulatory authority.
CDSCO's guidance specifically describes the need for systems to collect, process, and forward adverse drug reaction reports to the licensing authority.
2. Collect Adverse Event Information
Companies should have a proper process for receiving safety complaints and adverse event information.
Reports may come from:
Doctors
Hospitals
Patients
Pharmacists
Distributors
Clinical studies
Customer support teams
Other healthcare professionals
Each report should be properly documented and assessed according to the applicable procedure.
3. Evaluate Serious Adverse Reactions
Serious or unexpected adverse reactions require careful assessment.
The company should review the available information and determine whether additional investigation or regulatory reporting is required.
For applicable pharmaceutical products, CDSCO guidance requires serious adverse drug reactions to be reported to the concerned licensing authority according to the applicable regulatory requirements.
4. Maintain Safety Records
Pharmacovigilance is not limited to reporting individual incidents. Companies should maintain proper records of safety information and their evaluation.
These records can help demonstrate that the company has an effective post-market safety monitoring process.
5. Submit Periodic Safety Reports
Certain products require periodic safety reporting.
PSURs provide regulators with updated information about the safety profile of a product over a specific period. CDSCO's Post Marketing Drug Safety Monitoring Division currently processes PSUR submissions through the SUGAM system for applicable products.
The frequency and requirements can vary according to the product and applicable approval conditions.
Pharmacovigilance for Medical Devices
Pharmacovigilance is not limited to medicines. Medical device companies also need to pay attention to post-market safety surveillance.
Medical devices and in-vitro diagnostic medical devices are regulated under the applicable medical device framework in India. CDSCO has specifically highlighted the need for medical device licence holders to establish systems for timely identification, documentation, and reporting of adverse events.
For medical devices, post-market surveillance can include:
Monitoring complaints
Recording adverse events
Investigating device-related incidents
Identifying recurring problems
Taking corrective action
Reporting applicable events to the authorities
Maintaining relevant records
Companies planning CDSCO Medical device registration should therefore consider post-market safety requirements along with the initial regulatory approval.
Businesses importing devices should also understand the requirements connected with a CDSCO Medical Device import licence and the continuing responsibilities that apply after the licence is granted.
CDSCO Registration and Pharmacovigilance
Businesses often search for CDSCO Registration Online when planning to introduce regulated healthcare products into the Indian market.
However, obtaining registration or a licence is only one part of regulatory compliance. Depending on the product category, companies may also need systems for complaint handling, adverse event monitoring, post-market surveillance, safety reporting, and regulatory communication.
Therefore, businesses should consider compliance across the complete product lifecycle:
Product Development → Regulatory Approval → Manufacturing/Import → Market Launch → Safety Monitoring → Reporting → Corrective Action
This approach helps companies maintain regulatory records and respond properly when safety issues arise.
Pharmacovigilance and Cosmetics
Cosmetics have a separate regulatory framework under the Cosmetics Rules, 2020. CDSCO states that cosmetics manufactured or imported into India must comply with applicable quality and safety requirements, while imported cosmetics require registration under the applicable rules.
A business looking for a CDSCO cosmetic manufacturing license should therefore understand that cosmetic compliance is different from pharmaceutical pharmacovigilance.
Companies should pay attention to:
Product safety
Ingredient requirements
Quality standards
Labelling requirements
Manufacturing compliance
Consumer complaints
Adverse or undesirable reactions
Applicable regulatory reporting
The regulatory requirements depend on the type of cosmetic activity and whether the product is manufactured or imported.
Role of Post-Market Surveillance
Post-market surveillance helps regulators and businesses understand how a product performs after it reaches the market.
For medical devices, CDSCO has specifically described post-market surveillance as an important mechanism for ensuring the safety and performance of devices.
A practical post-market surveillance system can include:
Complaint collection
Complaint classification
Safety assessment
Investigation
Trend analysis
Regulatory reporting
Corrective and preventive action
Follow-up monitoring
Companies should maintain clear internal procedures so that safety complaints are not missed or delayed.
What Happens When a Safety Issue Is Identified?
When a potential safety issue is identified, the company should investigate the available information and determine the appropriate response under the applicable regulations.
Depending on the nature and seriousness of the issue, actions may include:
Additional safety monitoring
Product investigation
Corrective action
Changes to product information
Communication with healthcare professionals
Regulatory notification
Product recall or other regulatory action, where applicable
The appropriate action depends on the product, risk, evidence available, and applicable regulatory requirements.
How Can Businesses Prepare for Pharmacovigilance Compliance?
Businesses dealing with regulated healthcare products can take several practical steps:
Create a Written SOP
Prepare standard operating procedures for receiving, documenting, assessing, and reporting safety information.
Assign Responsibility
Identify the person or team responsible for pharmacovigilance and post-market safety activities.
Train Employees
Customer support, sales, medical, quality, regulatory, and other relevant teams should know how to identify and escalate safety complaints.
Maintain Documentation
Keep proper records of adverse events, complaints, investigations, assessments, reports, and actions taken.
Monitor Regulatory Updates
CDSCO regularly publishes regulatory notifications, circulars, guidance documents, and other updates. Businesses should review applicable changes regularly.
Review Product Safety Regularly
Do not wait for a major complaint before reviewing safety information. Regular monitoring can help identify recurring issues earlier.
CDSCO Compliance Support by Corpbiz
Regulatory compliance can become complex when a business deals with medicines, medical devices, cosmetics, or other regulated products.
Corpbiz Advisors assists businesses with regulatory and compliance requirements related to healthcare and other regulated sectors. Depending on the product and business activity, support may include understanding applicable approvals, preparing documentation, online application support, and compliance guidance.
Businesses can also seek professional guidance for areas such as CDSCO Registration Online, CDSCO Medical device registration, CDSCO Medical Device import license, and CDSCO cosmetic manufacturing license requirements.
Before applying, businesses should identify the exact product category, intended activity, manufacturing/import arrangement, and applicable regulatory authority because requirements can differ between products.
Frequently Asked Questions
1. What is pharmacovigilance under CDSCO?
Pharmacovigilance is the process of monitoring the safety of medicines and identifying, evaluating, documenting, and reporting adverse reactions and other safety concerns after a product is marketed.
2. Is pharmacovigilance required after product approval?
For applicable products, post-marketing safety monitoring continues after approval. The specific requirements depend on the product and applicable regulations and approval conditions. CDSCO's framework includes adverse event monitoring and periodic safety reporting for applicable products.
3. What is a PSUR?
PSUR stands for Periodic Safety Update Report. It provides updated information about the safety of a product during a specified period and is submitted to the regulator when required.
4. Does pharmacovigilance apply to medical devices?
Medical device businesses have post-market safety and surveillance responsibilities. CDSCO has highlighted the need for medical device licence holders to identify, document, and report applicable adverse events.
5. What is CDSCO Medical device registration?
CDSCO Medical device registration refers to the applicable regulatory registration or licensing process for medical devices under India's medical device regulatory framework. The exact requirement depends on the type and classification of the device.
6. Is a CDSCO Medical Device import license required?
Businesses importing regulated medical devices into India may require the applicable CDSCO licence or approval before importing and marketing the device. The exact requirement depends on the device and applicable rules.
7. What is CDSCO Registration Online?
CDSCO Registration Online generally refers to submitting an applicable regulatory application through the CDSCO's online systems. The specific application, documents, fees, and approval process depend on the product category and activity.
8. Does pharmacovigilance apply to cosmetics?
Cosmetics are regulated under the Cosmetics Rules, 2020, with requirements relating to safety, quality, manufacturing, import, registration, and other compliance matters. The requirements are different from pharmaceutical pharmacovigilance.
9. What is a CDSCO cosmetic manufacturing license?
It refers to the applicable regulatory licence/approval for manufacturing cosmetics in India. The requirements depend on the manufacturing activity and applicable provisions of the Cosmetics Rules, 2020.
10. Why is post-market surveillance important?
Post-market surveillance helps identify safety or performance issues after a product reaches the market. It allows businesses and regulators to investigate concerns and take appropriate action where necessary.
Conclusion
Pharmacovigilance is an important part of maintaining product safety after a healthcare product reaches the market. Companies should not view regulatory approval as the end of their compliance responsibilities.
Businesses dealing with medicines, medical devices, and cosmetics should understand the requirements that apply to their specific products and maintain appropriate systems for complaint handling, safety monitoring, documentation, and regulatory reporting.
Whether a business is planning CDSCO Registration Online, CDSCO Medical device registration, a CDSCO Medical Device import license, or a CDSCO cosmetic manufacturing license, understanding post-market compliance can help build a stronger regulatory process and support product safety.
Author Profile
Atul Shukla is a legal and compliance professional associated with Corpbiz Advisors. He writes about regulatory compliance, business laws, licensing, taxation, intellectual property, and industry-specific approvals. His content focuses on explaining complex compliance requirements in simple language so that businesses can make informed decisions.
